Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03875651 · ClinicalTrials.gov registry record
A Clinical Trial to Confirm Safety & Effectiveness of the SYNERGY 4.50 mm and 5.00 mm Stent for Treatment of Atherosclerotic Lesion(s)
A clinical trial, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- 100
- Enrollment target
NCT03875651 is a clinical trial that has completed, run by Boston Scientific Corporation. The registered enrollment target is 100 participants.
The verdict
NCT03875651 has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
EVOLVE 4.5/5.0 is a prospective, single-arm, multi-center observational (standard of care) trial intended to confirm the safety and effectiveness of the SYNERGY 4.50 mm and 5.00 mm Coronary Stent System for the treatment of patients with coronary artery disease in large vessels (≤ 28 mm in length, by visual estimate, in native coronary arteries \> 4.00 mm to ≤5.00 mm in diameter, by visual estimate). This Post Approval study is a cohort associated with the SYNERGY MEGATRON Post Approval Study, which is registered under ClinicalTrials.gov ID: NCT04807439.
Interventions
- DEVICE SYNERGY 4.50 mm and 5.0 mm Coronary Stent System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2019-05-09 |
| Est. Completion | 2023-11-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03875651
The ClinicalTrials.gov registry entry for NCT03875651 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SYNERGY 4.50 mm and 5.0 mm Coronary Stent System is the first listed.
NCT03875651 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03875651 about?
NCT03875651 is a clinical study titled "A Clinical Trial to Confirm Safety & Effectiveness of the SYNERGY 4.50 mm and 5.00 mm Stent for Treatment of Atherosclerotic Lesion(s)". EVOLVE 4.5/5.0 is a prospective, single-arm, multi-center observational (standard of care) trial intended to confirm the safety and effectiveness of the SYNERGY 4.50 mm and 5.00 mm Coronary Stent System for the treatment of patients with coronary artery disease in large vessels (≤ 28 mm in length, b...
What is the current status of trial NCT03875651?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2019-05-09. Estimated completion is 2023-11-28.
What interventions are being tested in trial NCT03875651?
The interventions under investigation include: SYNERGY 4.50 mm and 5.0 mm Coronary Stent System (DEVICE).
Who is sponsoring clinical trial NCT03875651?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.